Rapid differentiation of common respiratory infections can help support clinical assessment where patients present with similar respiratory symptoms. The Biopanda COVID-19/Influenza A+B/RSV Antigen Combo Rapid Test provides a convenient multiplex solution for the simultaneous detection of SARS-CoV-2, Influenza A+B and Respiratory Syncytial Virus (RSV) antigens from a single nasopharyngeal swab sample. Designed for professional use, this COVID-19, Flu and RSV rapid test enables three important respiratory infections to be screened within a single testing procedure, providing healthcare professionals and clinical laboratories with clear visual results in just 15 minutes.
Catalogue Number: RAPG-RSPV-003
Kit Size: 20 Tests
Assay Time: 15 minutes
Storage: 2-30°C
Specimen: Nasopharyngeal Swab
Results: Read visually
Description:
The Biopanda COVID-19 / Influenza A+B / RSV Antigen Combo lateral flow immuno-chromatographic assay is a qualitative test for the detection of SARS-CoV-2 Nucleocapsid protein, Influenza A+B, and Respiratory Syncytial Virus (RSV) antigens present in nasopharyngeal swab samples.
It is intended for use as a tool to assist in the diagnosis of SARS-CoV-2, Influenza A+B, and RSV infections, in conjunction with other tests.
This test is for in vitro diagnostic use only by a trained healthcare professional.
COVID-19, influenza and Respiratory Syncytial Virus (RSV) are respiratory infections that can cause similar signs and symptoms, including fever, cough, fatigue and other respiratory symptoms. As clinical presentation alone may not clearly identify the causative pathogen, testing can help support differential diagnosis and appropriate patient management.
Respiratory antigen testing detects viral antigens associated with infection. Testing for SARS-CoV-2, Influenza A+B and RSV simultaneously provides a convenient approach when investigating respiratory illness where several common viral pathogens may need to be considered.
A COVID-19, Flu and RSV combination test enables multiple respiratory pathogens to be screened from a single patient specimen within one testing procedure. This can provide a broader initial screening approach than testing for one respiratory pathogen alone.
The Biopanda COVID-19/Influenza A+B/RSV Antigen Combo Rapid Test qualitatively detects SARS-CoV-2 nucleocapsid protein, Influenza A+B and RSV antigens from nasopharyngeal swab samples, providing clear visual results in 15 minutes. The test provides healthcare professionals with a practical multiplex screening solution to assist in the diagnosis of respiratory infections alongside clinical assessment and other appropriate diagnostic procedures.
How to order:
Via the contact us page, fill in the form with all the necessary details and we will email you back ASAP.
Or, email us directly for general queries (please include the product catalogue number in the subject line, if applicable).